Factors Affecting the Price of Hernexeos

Store at 20~25°C (68~77°F); short-term exposure to 15~30°C (59~86°F) is permitted.

Keep in the original packaging to protect from moisture. Keep the bottle cap tightly closed and do not remove the desiccant.

Use up all the tablets within 3 months after opening; any remaining tablets must be discarded within 3 months of opening.

Keep out of the reach of children.

Zongertinib(Hernexeos)
Treatment of adult patients with advanced non-squamous non-small cell lung cancer (NSCLC) harboring HER2 TKD activating mutations following prior systemic therapy.
RELATED ARTICLES
How to Purchase Zongertinib

Zongertinib is a targeted therapeutic agent for non-small cell lung cancer (NSCLC) harboring activating mutations in...

Saturday, October 11th, 2025, 15:03
How to Purchase Zongertinib

Zongertinib is a targeted therapeutic drug for non-small cell lung cancer (NSCLC) harboring activating mutations in...

Sunday, September 28th, 2025, 16:15
/ 1
2 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved